Premier Alternatives

Algen

Discovery Tools (Healthcare) · San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of a medical platform designed to uncover disease-driving RNA messages. Algen is based in San Francisco, CA and was founded in 2018. It was valued at $24 million at its seed round in Feb 2022, the last priced event on record. It has raised $9.1 million across 1 recorded round; the latest was a $9 million seed round in Feb 2022.

PMV mark · valuation
$24.0M
Oct 2026
Priced at
its seed round
Feb 2022
Total raised
$9.1M
Last round
Seed Round
Feb 2022

Algen key facts

as of Oct 2026
  • Developer of a medical platform designed to uncover disease-driving RNA messages.
  • Algen is valued at approximately $24.0M as of Oct 2026, set at its seed round, Feb 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $9.1M across 1 recorded rounds; the latest was Seed Round ($9.0M) in Feb 2022.
  • Notable investors include Y Combinator, Viking Global Investors, Draper Associates, Endless Frontier Labs, Rebel Fund — 11 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$24.0M

Valued at $24.0M at its seed round, Feb 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Algen with a free account
  • ·The complete investor list: 11 names
  • ·Watch Algen: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Algen funding rounds

1 rounds
Feb 2022Seed Round$9.0M▮
Full funding history →

Algen valuation

Algen was valued at $24 million at its seed round in Feb 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Algen raised?

Algen has raised $9.1 million across 1 recorded round since 2022. The largest was a $9 million seed round in Feb 2022.

Algen investors

11 investors are on record for Algen, including Y Combinator, Viking Global Investors, Draper Associates and Endless Frontier Labs. The seed round in Feb 2022 drew 3 investors.

Comparable companies

Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: Nature's Toolbox ($71 million), Vitrivax ($69.4 million) and Xcell Biosciences ($65.5 million).

About Algen

Developer of a medical platform designed to uncover disease-driving RNA messages. The company's technology utilizes CRISPR gene-modulation and machine learning to find drugs that modulate RNA messages, including technologies and science to dissect complex disease signaling and gene networks, enabling drug companies to decode functional gene networks for drug discovery to find treatments for cancer and diseases with high unmet needs.

Industry
Discovery Tools (Healthcare)
Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2018
Employees
14
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.